SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary of Weighted Average Grant Date Fair Value and Share-Based Compensation Activity

The following tables provide the weighted average fair value of options, RSUs, and PSUs granted to employees during the year ended December 31, 2023, and the related weighted average stock option valuation assumptions used in the Black-Scholes model.

Weighted Average Grant Date Fair Value
(In dollars)	December 31, 2023
Stock options	$	25
RSUs	73
PSUs	85

Stock Option Activity
	Shares (in thousands)	Weighted average exercise price (in dollars)		Weighted average contractual term (in years)	Intrinsic value (in millions)
Outstanding as of January 4, 2023(1)	3,738	$	90
Granted	2,155	72
Exercised/Vested	(561)	60
Forfeited	(159)	71
Expired	(210)	127
Outstanding as of December 31, 2023	4,963	$	84	6.1	$	35
Exercisable as of December 31, 2023	2,810	$	94	3.8	$	23
Expected to vest	1,755	$	72	9.0	$	10

(1) Our common stock began “regular way” trading on The Nasdaq Stock Market LLC (“Nasdaq”) on January 4, 2023. The shares outstanding as of January 4, 2023 pertain to GE equity-based awards issued by GE in prior periods to employees of the Company that were converted to GE HealthCare equity-based awards as part of the Spin-Off.

Schedule of Stock Options Valuation Assumptions

Key Assumptions in the Black-Scholes Valuation for Stock Options
	December 31, 2023
Risk-free rate	3.6	%
Dividend yield	0.01	%
Expected volatility	26.2	%
Expected term (in years)	6.2

Schedule of RSU and PSU Activity

RSU and PSU Activity
	RSUs						PSUs
	Shares (in thousands)	Weighted average grant date fair value (in dollars)		Weighted average vesting period (in years)	Intrinsic value (in millions)		Shares (in thousands)	Weighted average grant date fair value (in dollars)		Weighted average vesting period (in years)	Intrinsic value (in millions)
Outstanding as of January 4, 2023(1)	3,551	$	58				1,365	$	68
Granted	1,904	73					539	85
Exercised/Vested	(1,317)	56					—	—
Forfeited	(409)	60					(483)	72
Expired	—	—					(175)	66
Outstanding as of December 31, 2023	3,729	$	67	1.5	$	290	1,246	$	85	1.4	$	96
Expected to vest	3,333	$	60	1.5	$	258	N/A	N/A		N/A	N/A

(1) Our common stock began “regular way” trading on Nasdaq on January 4, 2023. The shares outstanding as of January 4, 2023 pertain to GE equity-based awards issued by GE in prior periods to employees of the Company that were converted to GE HealthCare equity-based awards as part of the Spin-Off.

Summary of Share-Based Compensation Expense and Other Share-Based Compensation Data

Share-based Compensation Expense	For the year ended
	December 31, 2023
Share-based compensation expense (pre-tax)	$	114
Income tax benefits	(23)
Share-based compensation expense (after-tax)	$	91

Other Share-based Compensation Data
Unrecognized compensation expense as of December 31, 2023(1)	$	149
Cash received from stock options exercised in the year ended December 31, 2023	34
Intrinsic value of stock options exercised and RSU/PSUs vested in the year ended December 31, 2023	106

(1) Amortized over a weighted average period of 1.9 years.